argenx

argenx presents itself as an organization focused on immunology innovation, stating that "The science of co-creation drives our quest to engineer life-changing immunology solutions." Its name is explained as coming from the story of the Argonauts, and the company describes an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side. It states that it has a product approved for use in the United States and describes a one-tier board consisting of executive and non-executive directors, with an executive management team responsible for day-to-day operations.

argenx states that its name comes from the ancient myth of the Argonauts, described as one of the first stories on record recognizing the power of the team rather than one hero. The company says the Argonauts set out in a small boat on a wide ocean on a mission to find the golden fleece, a seemingly impossible task achieved through the collective effort of the team. argenx also states that it has created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side.

Reaching Patients Through Immunology Innovation

• 2021-12-17

  FDA approves Vyvgart for myasthenia gravis[5]FDA批准Vyvgart用于治疗重症肌无力healio.com

  Reported: 2021-12-17

  The FDA approved Vyvgart for adults with myasthenia gravis who are positive for acetylcholine receptor antibody.

• 2021-06-07

  Janssen affiliate announces end of cusatuzumab collaboration with argenx[6]强生旗下杨森关联公司宣布结束与argenx的cusatuzumab合作prnewswire.com

  Reported: 2021-06-07

  Cilag GmbH International, a Janssen Pharmaceutical Companies of Johnson & Johnson affiliate, announced that it would not continue its collaboration and license agreement with argenx for cusatuzumab. Janssen said it would work with argenx to transition the program back to argenx.

• 2021-03-31

  Pure MHC and argenx announce initial collaboration project[7]Pure MHC与argenx宣布启动首个合作项目enewschannels.com

  Reported: 2021-03-31

  Pure MHC announced an initial collaboration project with argenx to support a more robust understanding of how antigen presentation changes in the presence of specific therapeutic agents.

1. 1argenx | Homepage - Reaching Patients Through Immunology Innovationargenx.com
2. 2argenx | About - One Team, One Culture, One Purposeargenx.com
3. 3argenx | Products - Approved for use in the United Statesargenx.com
4. 4argenx | Governanceargenx.com
5. 5FDA批准Vyvgart用于治疗重症肌无力healio.com
6. 6强生旗下杨森关联公司宣布结束与argenx的cusatuzumab合作prnewswire.com
7. 7Pure MHC与argenx宣布启动首个合作项目enewschannels.com